Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masoud Najafi

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
Current Topics in Medicinal Chemistry|August 28, 2025
Natural-Derived Products and Nanomaterials for the Treatment of Cancer and Chronic Disorders (Part 1)Masoud Najafi
International Immunopharmacology|June 25, 2021
Resveratrol for targeting the tumor microenvironment and its interactions with cancer cellsQi Mu, Masoud Najafi
Critical Reviews in Oncology/Hematology|December 2, 2020
Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectivesKeywan Mortezaee, Masoud Najafi
European Journal of Pharmacology|July 24, 2021
Modulation of the tumor microenvironment (TME) by melatoninQi Mu, Masoud Najafi
Current Drug Targets|July 6, 2022
Redox Interactions in Chemo/Radiation Therapy-induced Lung Toxicity; Mechanisms and Therapy PerspectivesXixi Lai, Masoud Najafi
Inflammopharmacology|November 23, 2021
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agentsRun Yang, Changming Tan, Masoud Najafi
Journal of Cellular Physiology|October 15, 2018
Contribution of regulatory T cells to cancer: A reviewMasoud Najafi, Bagher Farhood, Keywan Mortezaee
Journal of Medical Physics|April 14, 2017
Bystander Effect and Second Primary Cancers following Radiotherapy: What are its Significances?Masoud Najafi, Ashkan Salajegheh, Abolhasan Rezaeyan
Journal of Cellular Biochemistry|October 16, 2018
Extracellular matrix (ECM) stiffness and degradation as cancer driversMasoud Najafi, Bagher Farhood, Keywan Mortezaee
Life Sciences|June 4, 2019
Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevanceMasoud Najafi, Keywan Mortezaee, Reza Ahadi
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
Current Topics in Medicinal Chemistry|August 28, 2025
Natural-Derived Products and Nanomaterials for the Treatment of Cancer and Chronic Disorders (Part 1)Masoud Najafi
International Immunopharmacology|June 25, 2021
Resveratrol for targeting the tumor microenvironment and its interactions with cancer cellsQi Mu, Masoud Najafi
Critical Reviews in Oncology/Hematology|December 2, 2020
Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectivesKeywan Mortezaee, Masoud Najafi
European Journal of Pharmacology|July 24, 2021
Modulation of the tumor microenvironment (TME) by melatoninQi Mu, Masoud Najafi
Current Drug Targets|July 6, 2022
Redox Interactions in Chemo/Radiation Therapy-induced Lung Toxicity; Mechanisms and Therapy PerspectivesXixi Lai, Masoud Najafi
Inflammopharmacology|November 23, 2021
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agentsRun Yang, Changming Tan, Masoud Najafi
Journal of Cellular Physiology|October 15, 2018
Contribution of regulatory T cells to cancer: A reviewMasoud Najafi, Bagher Farhood, Keywan Mortezaee
Journal of Medical Physics|April 14, 2017
Bystander Effect and Second Primary Cancers following Radiotherapy: What are its Significances?Masoud Najafi, Ashkan Salajegheh, Abolhasan Rezaeyan
Journal of Cellular Biochemistry|October 16, 2018
Extracellular matrix (ECM) stiffness and degradation as cancer driversMasoud Najafi, Bagher Farhood, Keywan Mortezaee
Life Sciences|June 4, 2019
Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevanceMasoud Najafi, Keywan Mortezaee, Reza Ahadi
Pageof 20